Editorial

The importance of independent drug bulletins

Andrew Herxheimer
  • 1 February 2002
  • 3 min read
Editorial

Changes at Australian Prescriber

The Executive Editorial Board
  • 1 February 2002
  • 3 min read
Letters to the Editor

Evidence-based medicine

Ken Harvey, Peteris Darzins, Majella Pugh
  • 1 February 2002
  • 3 min read
Patient support organisations

Diabetes Australia

  • 1 February 2002
  • 1 min read
Book review

Drugs and Pregnancy

Jane Talbot
  • 1 February 2002
  • 2 min read
Article

Hypertension in diabetes

Julia Lowe
  • 1 February 2002
  • 6 min read
Article

Influenza immunisation

Robert Hall
  • 1 February 2002
  • 7 min read
Medicinal mishap

Serotonin syndrome

  • 1 February 2002
  • 2 min read
Article

I've missed a dose; what should I do?

Andrew Gilbert
  • 1 February 2002
  • 6 min read
Article

Clinical intuition: more than rational?

Glyn Brokensha
  • 1 February 2002
  • 5 min read
Article

Does pethidine still have a place in therapy?

Allan Molloy
  • 1 February 2002
  • 5 min read
NEW DRUGS
Darbepoetin alfa
  • 1 January 2002
  • 2 min read
Cefotaxime
  • 1 January 2002
  • 1 min read
Pioglitazone hydrochloride
  • 1 January 2002
  • 2 min read
Zoledronic acid
  • 1 January 2002
  • 2 min read
Laureth-9
  • 1 January 2002
  • 2 min read
Carvedilol
  • 1 January 2002
  • 1 min read
Follitropin beta
  • 1 January 2002
  • 1 min read
Rivastigmine
  • 1 January 2002
  • 1 min read
Flunitrazepam
  • 1 January 2002
  • 1 min read
Alprazolam
  • 1 January 2002
  • 1 min read
Oxcarbazepine
  • 1 January 2002
  • 2 min read
Sibutramine hydrochloride
  • 1 January 2002
  • 3 min read
Somatropin
  • 1 January 2002
  • 1 min read
Etanercept
  • 1 January 2002
  • 2 min read